SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase
- 1 June 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (11) , 2231-2236
- https://doi.org/10.1016/0006-2952(88)90586-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The specificity of omeprazole as an (H++K+)-ATPase inhibitor depends upon the means of its activationBiochemical Pharmacology, 1987
- Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080Biochemical Pharmacology, 1987
- Mechanism of gastric antisecretory effect of SCH 28080British Journal of Pharmacology, 1986
- Studies on the mechanism of action of omeprazoleBiochemical Pharmacology, 1985
- Inhibition of H+K+ ATPase by SCH 28080 and SCH 32651European Journal of Pharmacology, 1985
- Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cellBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Inhibition of (
H K ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil anddiethylamino)octyl -3,4,5-trimethoxybenzoate Biochimica et Biophysica Acta (BBA) - Biomembranes, 1984 - The catalytic cycle of gastric (H+ + K+)-ATPase.Journal of Biological Chemistry, 1980
- Potassium-stimulated ATPase activity and hydrogen transport in gastric microsomal vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- On the reversibility of binding of cardiotonic steroids to a partially purified (Na + K)-activated adenosinetriphosphatase from beef brainBiochemical and Biophysical Research Communications, 1970